Which has grown faster, AGEN or IRD?

Over the past five years, IRD grew revenue faster — AGEN at a 14.13% CAGR versus IRD at 150.49%.

Is AGEN or IRD more profitable?

AGEN runs the higher net margin — AGEN at 69.34% versus IRD at -1091.82%.

Agenus Inc. (AGEN) vs Opus Genetics, Inc. (IRD)

A side-by-side comparison of Agenus Inc. and Opus Genetics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

AGEN

Agenus Inc.

$330M

$7.92HealthcareDelayed quote: Oct 6, 2026, 12:55 PM EDT

IRD

Opus Genetics, Inc.

$363M

$4.40HealthcareDelayed quote: Oct 6, 2026, 12:50 PM EDT

Total return — AGEN vs IRD

growth of $100 · dividends reinvested · last 2y

AGEN +49.5% (+22.3%/yr)IRD +239.5% (+84.3%/yr)IRD compounded faster over this window

AGEN IRD

AGEN vs IRD: by the numbers

•IRD is the larger company ($363M vs $330M market cap).
•AGEN is profitable (69.34% net margin) while IRD runs a net loss (-1091.82%).
•IRD grew revenue faster over the past five years (150.49% vs 14.13% CAGR).

Metrics side by side

Valuation

Metric	AGEN	IRD
P/E ratio	2.99	N/A
Forward P/E	29.61	N/A
P/S ratio	2.49	36.82
EV / EBITDA	8.60	N/A

Profitability

Metric	AGEN	IRD
Gross margin	29.63%	99.87%
Operating margin	-18.00%	-271.90%
Net margin	69.34%	-1091.82%
ROIC	N/A	-59.29%

Growth (annualized)

Metric	AGEN	IRD
Revenue CAGR (5Y)	14.13%	150.49%
Total return CAGR (5Y)	-40.10%	N/A

Frequently asked

Which has grown faster, AGEN or IRD?: Over the past five years, IRD grew revenue faster — AGEN at a 14.13% CAGR versus IRD at 150.49%.
Is AGEN or IRD more profitable?: AGEN runs the higher net margin — AGEN at 69.34% versus IRD at -1091.82%.

Go deeper

Full AGEN analysis Full IRD analysis Interactive comparison tool

Dig into the metrics

Agenus P/E ratio Agenus ROE Opus Genetics ROE Agenus operating margin Opus Genetics operating margin Agenus revenue growth Opus Genetics revenue growth Agenus free cash flow Opus Genetics free cash flow

Agenus & Opus Genetics appear in these rankings

Fastest Revenue Growth Stocks Lowest P/E Ratio Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.